Lista de Citas

264 citas (Sin autocitas)
En azul las citas desde libros de editoriales prestigiadas, en amarillo las citas desde tesis doctorales, artículos solo con DOI,  arxiV o BioArxiv.

1.-Marvin A. Soriano-Ursúa, Ignacio Valencia-Hernández, Mónica G. Arellano-Mendoza, José Correa-Basurto, José G. Trujillo-Ferrara. Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a β2 adrenoceptor agonist. Eur J Med Chem. 2009, 44: 2840-2846.

1.              A. Congreve, M., Langmead, C. Marshall, F.H. The Use of GPCR Structures in Drug Design (book) Pharmacology of GPCRs. Advances in Pharmacology. 2011, 62:1-36. ISBN:978-0-12-385952-5

2.              A. Aimun A.E. Ahmed, Arpad Marki, Robert Gaspar, Andrea Vasas, M.M.E. Mudawi, Judit Verli, Balázs Jójárt, Judit Hohmann, George Falkay. β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: In vitroand in silico studies. European Journal of Pharmacology. 2011, 667:348-354.

3.               A. Aimun A. E. Ahmed, Arpad Marki, Robert Gaspar, Andrea Vasas, M. M. E. Mudawi, Balázs Jójárt, Renáta Minorics, Judit Hohmann and George Falkay. In silico and in vitro pharmacological investigations of a natural alkaloid. Medicinal Chemistry Research. 2012,21:4100-4107.

4.              A. Aimun Abdelgaffar Elhassan Ahmed. Pharmacological investigations of natural β2-adrenoceptors agonists on rat uterus in vitro and in silico studies (2012). Ph.D. Thesis. Faculty of Pharmacy, Department of Pharmacodynamics and Biopharmacy. University of Szeged, Hungary. http://doktori.bibl.u-szeged.hu/1330/1/Aimun_PhD_Thesis_Final_-_Nagy.pdf

5.          A. Emery AC. Chapter Sixteen - Catecholamine Receptors: Prototypes for GPCR-Based Drug Discovery. Advances in Pharmacology, 2013; 68:335-356.

6.              A. Emery AC. At: Eiden L.E. A New Era of Catecholamines in the Laboratory and Clinic (book). Academic Press, Sep 17, 2013. ISBN:978-0-12-411512-5. ISSN:1054-3589.

7.              A. Vilar, S., Sobarzo-Sanchez, E., Santana, L., & Uriarte, E. (2017). Molecular docking and drug discovery in β-adrenergic receptors. Current medicinal chemistry, 24(39), 4340-4359.

8.              B. Bello, M. (2018). Advances in Theoretical Studies on the Design of Single Boron Atom Compounds. Current Pharmaceutical Design, 24(29), 3466-3475.

9.              A. Acher, F., Battaglia, G., Bräuner-Osborne, H., Conn, P. J., Duvoisin, R., Ferraguti, F., ... & Johnson, M. P. (2019). Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE, 2019(4).

2.- Marvin A. Soriano-Ursúa, José G. Trujillo-Ferrara, José Correa-Basurto. Homology modeling and flex-ligand docking studies on the guinea pig beta-2 adrenoceptor: structural and experimental similarities/differences with the human beta-2. J Mol Model. 2009, 15: 1203-1211.

(10) 1.         A. Congreve, M., Langmead, C.J.,Mason, J.S., Marshall, F.H. Progress in structure based drug design for G protein-coupled receptors. Journal of Medicinal Chemistry. 2011, 54 (13):4283-4311.

(11) 2.         A. Congreve, M., Langmead, C.,Marshall, F.H. The Use of GPCR Structures in Drug Design (book) Pharmacology of GPCRs. Advances in Pharmacology. 2011, 62:1-36. ISBN:978-0-12-385952-5.

(12) 3.         B. Bermúdez-Lugo, Jorge Antonio, Perez-Gonzalez O, Rosales-Hernández MC, Ilizaliturri-Flores I, Trujillo-Ferrara J, Correa-Basurto J. 2011. Exploration of the valproic acid binding site on histone deacetylase 8 using docking and molecular dynamic simulations. Journal of Molecular Modeling. 2012, 18(6):2301-2310.

(13) 4.          A. Zhang, R., Dong L., Ling B., Wang Z., Liu Y. Activation of β2-Adrenergic Receptor Induced by Three Catecholamine Agonists: a Docking and Molecular Dynamics Study. Chem. Res. Chinese Universities. 2012, 28(3), 493—499.

(14) 5.         A. Fragkaki AG, Georgakopoulos C, Sterk S, Nielen MWF. Sports doping: Emerging designer and therapeutic beta 2-agonists. Clinica chimica acta. 2013, 425:242-258.  

(15) 6.         A. DN Das, PK Panda, S Mukhopadhyay, N Sinha, B Mallick, B Behera, TK Maiti, SK Bhutia. Prediction and validation of apoptosis through cytochrome P450 activation by benzo[a]pyrene. Chemico-biological interactions. 2014. 208:8-17. http://dx.doi.org/10.1016/j.cbi.2013.11.005

(16) 7.         A. Vilar, S., Sobarzo-Sanchez, E., Santana, L., & Uriarte, E. (2017). Molecular docking and drug discovery in β-adrenergic receptors. Current medicinal chemistry, 24(39), 4340-4359.

(17) 8.         A. Al Olaby Reem Rafik. In silico design of selective high affinity ligands against HCV using novel computational biology tools. M.D. Thesis. Pharmaceutical Sciences, Ain Shams University, Cairo.URI: http://dar.aucegypt.edu/handle/10526/899

3. Soriano-Ursúa MA, Correa-Basurto J, Romero-Huerta J, Elizalde-Solis O, Galicia-Luna LA, Trujillo-Ferrara JG. Pharmacokinetic parameters and a theoretical study about metabolism of BR-AEA (a salbutamol derivative) in rabbit. J Enz Inh Med Chem. 2010, 25(3):340-346.

(18) 1.         A.  Ashton Acton, Book: Enzymes and Coenzymes: Advances in Research and Application: 2011 Edition. EscholarlyEditions™, ISBN: 978-1-4649-2073-8, Pp:127-128.

(19) 2.         A. S Harsha, AB Nair, M Attimarad, KN Venugopala, SA Kedarnath. Pharmacokinetics and tissue distribution of microspheres prepared by spray drying technique: targeted drug delivery. Biomedical Research, 2017. 28(8):387-3396.

4.- Marvin A. Soriano-Ursúa, José G. Trujillo-Ferrara, José Correa-Basurto. Docking studies on a refined human beta2 adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists. J Mol Model 2010, 16(3):401-409.

(20) 1.         A. Aimun A.E. Ahmed, Arpad Marki, Robert Gaspar, Andrea Vasas, M.M.E. Mudawi, Judit Verli, Balázs Jójárt, Judit Hohmann, George Falkay. β2-Adrenergic activity of 6-methoxykaempferol-3-O-glucoside on rat uterus: In vitroand in silico studies. European Journal of Pharmacology. 2011, 667:348-354.

(21) 2.         A. Jozwiak K, Toll L, Jimenez L, Woo AY, Xiao RP, Wainer IW. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor. Biochemical Pharmacology. 2010, 79(11):1610-1615.

(22) 3.         A. J. C. Phillips. Self-Organized Criticality in Proteins: Hydropathic Roughening Profiles of G-Protein Coupled Receptors. Dept. of Physics and Astronomy, Rutgers University, Piscataway, N. J., 08854. arXiv:1011.4286.

(23) 4.         A. Francesca Fanelli and Pier G. De Benedetti. Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors. Chemical Reviews, 2011, 111(12):PR438–PR535.

(24) 5.         A. Aimun A. E. Ahmed, Arpad Marki, Robert Gaspar, Andrea Vasas, M. M. E. Mudawi, Balázs Jójárt, Renáta Minorics, Judit Hohmann and George Falkay. In silico and in vitro pharmacological investigations of a natural alkaloid. Medicinal Chemistry Research. 2012, 21:4100-4107.

(25) 6.         A. Aimun Abdelgaffar Elhassan Ahmed. Pharmacological investigations of natural β2-adrenoceptors agonists on rat uterus in vitro and in silico studies.(2012) Ph.D. Thesis. Faculty of Pharmacy, Department of Pharmacodynamics and Biopharmacy. University of Szeged, Hungary. http://doktori.bibl.u-szeged.hu/1330/1/Aimun_PhD_Thesis_Final_-_Nagy.pdf

(26) 7.         B. Correa-Basurto J, Ramos-Morales FR, Matus MH, Rosales-Hernández MC, Mancilla-Percino T, Trujillo-Ferrara JG,  Ilizaliturri-Flores I. Docking and DFT Studies to explore the Topoisomerase II ATP Pocket employing 3-Substituted 2,6-Piperazindiones for drug design. Molecular Simulations. 2012, 38 (13):1072-1084.

(27) 8.         A. J. C. Phillips. Self-Organized Criticality in Proteins: Hydropathic Roughening Profiles of G-Protein Coupled Receptors. Phys Rev E: 2013, 87(3):032709.

(28) 9.         B. Vilar, S., Sobarzo-Sanchez, E., Santana, L., & Uriarte, E. (2017). Molecular docking and drug discovery in β-adrenergic receptors. Current medicinal chemistry, 24(39), 4340-4359

(29) 10.      A. Miroshnichenko, A. G., Bulgakova, Y. S., Perfiliev, V. Y., & Bazarnova, N. G. (2017). Levosalbutamol as alternative to drugs on the basis of racemic salbutamol: Review of the results of pre-clinical research. Regulatory Mechanisms in Biosystems, 8(4), 583-595.

5.- Marvin A. Soriano-Ursúa, José G. Trujillo-Ferrara, and José Correa-Basurto. Scope and difficulty in generating theoretical insights regarding ligand recognition and activation of the ß2 adrenergic receptor. J Med Chem 2010, 53:923-922.

(30) 1.         A. Congreve, M., Langmead, C., Marshall, F.H. The Use of GPCR Structures in Drug Design (book) Pharmacology of GPCRs. Advances in Pharmacology. 2011, 62:1-36.

(31) 2.         A. Kaszuba, K., Róg, T., Bryl, K., Vattulainen, I., Karttunen, M. Molecular dynamics simulations reveal fundamental role of water as factor determining affinity of binding of β-blocker nebivolol to β2-adrenergic receptor. Journal of Physical Chemistry B 2010, 114 (25):8374-8386.

(32) 3.         A. Francesca Fanelli and Pier G. De Benedetti. Computational Modeling Approaches to Structure–Function Analysis of G Protein-Coupled Receptors. Chemical Reviews, 2011, 111 (12):PR438–PR535.

(33) 4.         A. Anne Katrin Wolf. Zum Einfluss der Saponine aus Hedera helix L. auf die homologe Desensitivierung des b2-adrenergen Rezeptors und das Relaxationsverhalten der glatten Bronchialmuskulatur. PhD Thesis. Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn. http://nbn-resolving.de/urn:nbn:de:hbz:5N-21201

(34) 5.         B. Jesús Servando Medel Matus, Fernando Rafael Ramos Morales, José Correa Basurto, Jesús Samuel Cruz Sánchez, Margarita Virginia Saavedra Vélez, Vicente Velásquez Melgarejo.  Participación de los canales de calcio dependientes de voltaje en el desarrollo de la epilepsia. Acta bioquímíca clínica latinoamericana. 2010, 44:329-335.

(35) 6.          A. Topiol S. X-ray structural information of GPCRs in drug design: what are the limitations and where do we go? Expert Opinion on Drug Discovery, 2013, 8(6):613-620.

(36) 7.         B. M. Citlalli Contreras-Romo, José Correa-Basurto, Itzia Padilla-Martínez,  Marlet Martínez-Archundia, Federico Martínez-Ramos, Magdalena J. Ślusarz, Gilberto López-Pérez,  Andrés Quintanar-Stephano. Theoretical studies, synthesis, and biological activity of 1-[(4-methylphenyl)sulfonyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-4-carbonitrile (C9) as a non-peptide antagonist of the arginine vasopressin V1a and V2 receptors. Medicinal Chemistry Research 2013, 23(3) 1581:1590.

(37) 8.         B. Contreras-Romo MC, Martínez-Archundia M, Deeb O, Slusarz MJ, Ramírez-Salinas G, Garduño-Juárez R, Quintanar-Stephano A, Ramírez-Galicia G, Correa-Basurto J. Exploring the ligand recognition properties of the human vasopressin V1a receptor using QSAR and molecular modeling studies. Chem Biol Drug Des. 2014, 83(2):207-223.

(38) 9.         A. Ayala-Soldado N. Estudio comparativo de los efectos de los anestésicos Metasulfonato de Tricaina (MS-222) y Eugenol para su uso en el pez cebra (Danio rerio) como modelo experimental. PhD Thesis. 2015. Universidada de Córdoba. España.URI: http://hdl.handle.net/10396/12677

(39) 10.   A. Christian Brütting, Dr. Ronny Hesse, Anne Jäger, Dr. Olga Kataeva, Dr. Arndt W. Schmidt, Prof. Dr. Hans-Joachim Knölker. Synthesis of Glycoborine, Glybomine A and B, the Phytoalexin Carbalexin A and the β-Adrenoreceptor Antagonists Carazolol and Carvedilol. Chemistry A European Journal. 2016, 22, 16897-16911. DOI: 10.1002/chem.201604002.

(40) 11.   A. Liu G, Wang C, Li C, Wang J, Sun Z, Zhao X, Zheng X. Confirming therapeutic target of protopine using immobilized B2-adrenoceptor coupled with site-directed molecular docking and the target-drug interaction by frontal  analysis and injection amount-dependent method. J Mol Recognit. 2017.  doi: 10.1002/jmr.2613.

6.- Soriano-Ursúa MA, Correa-Basurto J, Valencia-Hernández I, Amezcua-Gutiérrez MA, Padilla-Martínez II, Trujillo-Ferrara JG Design, synthesis and in vitro evaluation of (R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenyl hydrogen phenylboronate: a novel salbutamol derivative with high intrinsic efficacy on the beta2-adrenoceptor. Bioorg Med Chem Lett. 2010. 20: 5623–5629.

(41) 1.         A. Shan WJ, Huang L, Zhou Q, Jiang HL, Luo ZH, Lai KF, Li XS. Dual β(2)-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 2012, 22(4):1523-1526.

(42) 2.         A. Ashton Acton. Book: Gases: Advances and Research in applications. 2011 Edition. Escholarly Editions™, ISBN: 978-1-4649-2063-9, pp:784.

(43) 3.         A. Zhang waves, Zhang Rongzhen Wang Shanshan, Xu Yan. Site-directed mutagenesis to change parapsilosis Candida SCR II catalytic acetophenone derivatives substrate spectrum. Microbial Journal, 2011 –cqvip: 214122. http://www.cqvip.com/qk/94144x/201106/38109981.html

(44) 4.         A. Liu A, Huang L, Wang Z, Luo Z, Mao F, Shan W, Xie J, Lai K, Li X. Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD. Bioorganic & Medicinal Chemistry Letters. 2013;23:1548-1552. 

(45) 5.         A. Fragkaki AG, Georgakopoulos C, Sterk S, Nielen MWF. Sports doping: Emerging designer and therapeutic beta 2-agonists. Clinica chimica acta. 2013, 425:242-248.

(46) 6.         A. Huang L,  Shan W,  Zhou Q,  Xie J,  Lai L, Li X. Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 2014; 24:249-253.

(47) 7.         B. Vilar, S., Sobarzo-Sanchez, E., Santana, L., & Uriarte, E. (2017). Molecular docking and drug discovery in β-adrenergic receptors. Current Medicinal Chemistry, 24(39), 4340-4359

(48) 8.         A. Congreve, M., Bortolato, A., Brown, G., & Cooke, R. M. (2017). Modeling and Design for Membrane Protein Targets. 145-188. DOI: 10.1016/B978-0-12-409547-2.12358-3. In book: Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, Elsevier.

(49) 9.         A. Bello, M. (2018). Advances in Theoretical Studies on the Design of Single Boron Atom Compounds. Current Pharmaceutical Design, 24(29), 3466-3475.

7.- Soriano-Ursúa MA, Correa-Basurto J, Trujillo-Ferrara JG, Kaumann AJ. Homology model and docking studies on porcine β2 adrenoceptor: description of two binding sites. J Mol Model. 2011. 17(10):2525-38.

(50) 1.         B.  Tolentino-López L, segura-Cabrera A, Reyes Loyola P, et al. Outside-Binding Site Mutations Modify the Active Site’s Shapes in Neuraminidase from Influenza A H1N1. Biopolymers, 2012, 99(1):10-21.

(51) 2.         A. Yang L, Lin H, Xi Q, Ding J, Liu X, Shu G, Jiang Q, Wang X, Zhang Y. Polyantibody against β2-adrenergic receptor extracellular domain act as an agonist to this receptor in porcine model. Livestock science, 2012, 150:248-255.

(52) 3.         A. Zhou C, Hou C,  Zhang Q, Wei X. Enhanced hybrid search algorithm for protein structure prediction using the 3D-HP lattice model. Journal of Molecular  Modeling, 2013, 19(9):3883:3891.

(53) 4.         A. Segretti, N. D. (2016). Planejamento e síntese de tuberculostáticos potenciais com base na estrutura de maltosiltransferase (GlgE) de Mycobacterium tuberculosis (Doctoral dissertation, Universidade de São Paulo,Brazil). DOI: 10.11606/T.9.2017.tde-24042017-101741

(54) 5.         A. Fretter Y. Biochemische und biophysikalische Charakterisierung von G‐Protein‐gekoppelten Rezeptoren. PhD Thesis. 2016. Bochum, Germany 2016. urn:nbn:de:hbz:294-51309                                                                             https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/year/2017/docId/5130 

(55) 6.         B. Ramírez-Salinas, G. L., Garcia-Machorro, J., Quiliano, M., Zimic, M., Briz, V., Rojas-Hernández, S., & Correa-Basurto, J. (2015). Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase. Journal of Molecular Modeling, 21(11), 292.

8.- Soriano-Ursúa MA, Ocampo-López JO, Ocampo-Mendoza K, Trujillo-Ferrara JG, Correa-Basurto J. Theoretical study about high 3-D molecular similarity and ligand binding modes of orthologous human/rat D2 dopamine receptor. Comput Biol Med. 2011. 41(7):537-545.

(56) 1. A. Feng Z, Hou T, Li Y. Selectivity and activation of dopamine D3R from molecular dynamics. J Mol Model. 2012; 18(12):5051-5063.

(57) 2. A. G Zanatta, IL Barroso-Neto, V Bambini-Junior, et al. Quantum Biochemistry Description of the Human Dopamine D3 Receptor in Complex with the Selective Antagonist Eticlopride. J Proteomics Bioinform, 2012, 5(7): 155-162.

(58) 3. A. Javier Párraga, Nuria Cabedo, Sebastián Andujar, Laura Piqueras, Laura Moreno, Abraham Galán, Emilio Angelina, Ricardo D. Enriz, María Dolores Ivorra, María Jesús Sanz, Diego Cortes. 2,3,9- and 2,3,11-Trisubstituted Tetrahydroprotoberberines as D2 Dopaminergic Ligands. Eur J Med Chem, 2013, 68:150-156.

(59) 4. A. G Zanatta, G Nunes, EM Bezerra, et al. Antipsychotic Haloperidol Binding to the Human Dopamine D3 Receptor: Beyond Docking Through QM/MM Refinement Towards the Design of Improved Schizophrenia Medicines. ACS Chem Neurosci. 2014, 5(10): 1041-1054.

(60) 5. A. Angelina E, Andujar S, Moreno L, Garibotto F, Párraga J, Peruchena N, Cabedo N, Villecco M, Cortes D, Enriz RD. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity. Mol. Inf. 2014, DOI: 10.1002/minf.201400093.

(61) 6. A. Sukalovic V, Soskic V, Kostic-Rajacic S. Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution. Curr Med Chem. 2015;22(25):2972-90.

(62) 7. A. Párraga J, Andújar SA, Rojas S, et al.  Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands. Eur J Med Chem, 2016; 122, 27-42. doi:10.1016/j.ejmech.2016.06.009

(63) 8. A. AM Luchi, EL Angelina, SA Andujar, et al. Halogen bonding in biological context: a computational study of D2 dopamine receptor. Journal of Physical Organic Chemistry, 2016. DOI:10.1002/poc.3586.

(64) 9. A. Ewa Szymańska, Anna Drabczyńska, Tadeusz Karcz, Christa E. Müller, Meryem Köse,  Janina Karolak-Wojciechowska,  Andrzej Fruziński, Jakub Schabikowski, Agata Doroz-Płonka, Jadwiga Handzlik, Katarzyna Kieć-Kononowicz. Similarities and differences in affinity and binding modes of tricyclic pyrimido- and pyrazinoxanthines at human and rat adenosine receptors. Bioorg Med Chem. 2016. 24(18):4347-4362. doi:10.1016/j.bmc.2016.07.028

(65) 10. A. Jelena Z. Penjišević. Dopamine D2 receptor binding site study by newly synthesized 2-methoxyphenylpiperazine ligands. Doctorate dissertation. Beograd, 2016. UDK number: 547.8. URI: http://eteze.bg.ac.rs/application/showtheses?thesesId=4906   http://cherry.chem.bg.ac.rs/handle/123456789/2717 

(66) 11. B. Andrade-Jorge, E., Bahena-Herrera, J.R., Garcia-Gamez, J. et al. Novel synthesis of isoindoline/isoindoline-1, 3-dione derivatives under solventless conditions and evaluation with the human D2 receptor. Med Chem Res (2017). doi:10.1007/s00044-017-1942-6

(67) 12. A. Soskic, V., Sukalovic, V., & Kostic-Rajacic, S. (2015). Exploration of N-arylpiperazine Binding Sites of D2 Dopaminergic Receptor. Mini Reviews in Medicinal Chemistry, 15(12), 988-1001.

(68) 13. A. Párraga Vidal, J. Síntesis de Protoberberinas y Ciclopentil-isoquinoleínas Dopaminérgicas, y Síntesis de Indenopiridinas Melatoninérgicas. Ph.D Thesis. Departamento de Farmacología, Universida de Valencia, España. http://roderic.uv.es/handle/10550/42779

(69) 14. A. Nandy, A., & Adhikari, I. (2018). Application of Chemoinformatic Tools for the Design of Novel Molecules as anti-Parkinsonian Agents. Current Signal Transduction Therapy, 13(2), 119-128.

(70) 15. A. Montgomery, D., Campbell, A., Sullivan, H. J., & Wu, C. (2018). Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity. Journal of Biomolecular Structure and Dynamics, 37(12), 3206-3225. Doi: 10.1080/07391102.2018.1513378.

9.- López-Hernández LB, Van Heusden D, Soriano-Ursúa MA, Figuera-Villanueva L, Vázquez-Cárdenas NA, Sandoval-Ramírez L, Canto P, Gómez-Díaz B and Coral-Vázquez RM. Genotype-phenotype discordance in Duchenne Muscular Dystrophy patient due to a novel mutation. Rev. Neurol. 2011. 52(12):720-724.

(71) 1.              B. Ramón Mauricio Coral Vázquez, Luz Berenice López Hernández, Luis Ángel Ruano Calderón, Benjamín Gómez Díaz, Francisca Fernández Valverde, Eliganty Bahena Martínez. Distrofias musculares en México: un enfoque clínico, bioquímico y molecular. Revista de Especialidades Médico-Quirúrgicas 2010;15(3):152-160.

(72) 2.              A. Sarkis, Joe, Nov 2011. Mécanismes Moléculaires impliqués dans les Myopathies: Analyses des interactions Dystrophine-Lipides. Ph.D. Thesis. UNIVERSITÉ DE RENNES, France.http://www.theses.fr/2011REN1B155

(73) 3.              B.   J Fokkema, S López-Hernández, LB López-Hernández. Impacto de las organizaciones de padres en la investigación de la distrofia muscular de Duchenne: el activismo materno como motor de cambio. Revista de Investigación en Discapacidad. 2013; 2(3):135-140.

(74) 4.              A. Liang YY, Cao JQ, Yang J, Zhang C. Effects of the dystrophin hydrophobic regions in the pathogenesis of Duchenne muscular dystrophy: A three-dimensional reconstruction verification. Zhongguo Zuzhi Gongcheng Yanjiu. 2013;17(50):8703-871.

(75) 5.              B. Luz Berenice López-Hernández, Benjamín Gómez-Díaz, Eliganty Bahena-Martínez, Teresa Neri-Gómez, Alejandra Camacho-Molina, Luis A. Ruano-Calderón, Silvia García And Ramón M. Coral-Vázquez. A novel noncontiguous duplication in the DMD gene escapes the 'reading-frame rule'. J. Genetics. 2014, 93(1)225-229.

(76) 6.              B. Vázquez-Cárdenas NA, Ibarra-Hernández F, López-Hernández LB, Escobar-Cedillo RE, Ruano-Calderón LA, Gómez-Díaz B, García-Calderón N, Carriedo-Dávila MF, Rojas-Hurtado LG, Luna-Padrón E, Coral-Vázquez RM. Diagnosis and treatment with steroids for patients with Duchenne muscular dystrophy: experience and recommendations for Mexico. Rev Neurol. 2013;57(10):455-62.

(77) 7.              A. Y Liang, S Chen, J Zhu, X Zhou, C Yang, L Yao, C Zhang. Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies. Bosnian J Bas Med Sci. 15(2): 42-49. Doi: dx.doi.org/10.17305/bjbms.2015.300

(78) 8.              A. Ribeiro, P. M. N. (2017). Natação previne comprometimento da memória por aumentar defesa anti-oxidante em um modelo animal de distrofia muscular de Duchenne. Pós-Graduação em Ciência da Saúde, Universidade do sul do Santa Catarina, Brazil. http://www.riuni.unisul.br/handle/12345/2822

(79) 9.              A. Escobar-Cedillo, R. E., Tintos-Hernández, J. A., Martínez-Castro, G., de Oca-Sánchez, B. M., Rodriguez-Jurado, R., Miranda-Duarte, A., ... & Lopez-Hernandez, L. B. (2013). L-carnitine supplementation in duchenne muscular dystrophy steroid-naive patients: A pilot study. Current Topics in Nutraceuticals Research, 11(3), 97.

(80) 10.           A. Pérez-Moreno, J. C., Madrigal-Morales, R., Torres-Olmos, C., & Villanueva-Ayala, D. (2016). Gait analysis in patients with Duchenne muscular dystrophy with functional level 2, 3 and 4 on the scale of Vignos. Revista Mexicana de Medicina Física y Rehabilitación, 28(1-2), 19-27.

10.- Soriano-Ursúa MA, Mancilla-Percino T, Correa-Basurto J, Querejeta E and Trujillo-Ferrara JG. Give boron a chance: Boron containing compounds reach ionotropic and metabotropic transmembrane receptors.  Mini Rev Med Chem. 2011. 11(12): 1031-1038.

(81) 1.         B. Tamay-Cach F, Correa-Basurto J, Villa-Tanaca L, Mancilla-Percino T, Juárez-Montiel M, Trujillo-Ferrara JG.  Evaluation of new antimicrobial agents on Bacillus spp. strains: docking affinity and in vitro inhibition of glutamate-racemase. Journal of Enzyme Inhibition and Medicinal Chemistry. 2012, 28(5):1026-1033.

(82) 2.         A.  Joel Martínez J, Romero-Vega S, Abeja-Cruz R, Álvarez-Toledano C, Miranda R. Green Approach—Multicomponent Production of Boron—Containing Hantzsch and Biginelli Esters. Int. J. Mol. Sci. 2013, 14, 2903-2915

(83) 3.         A. B.S. Sekhon. Metalloid compounds as drugs. Research in Pharmaceutical Sciences, August 2013; 8(3): 145-158.

(84) 4.         A. J Martínez, V Abarca, FJ Pérez, V Carranza, R Miranda. Thioglycerol matrix interactions in the positive ion fast atom bombardment mass spectrometry of several Hantzsch and Biginelli ester derivatives of boronic acids. Rapid communications in mass spectrometry. 2013, 27(13):1573-8.

(85) 5.         A. Özdemir, A. (2016). Biomacromolecules, molecules and functional nanoparticles for therapeutic and diagnostic applications (Doctoral dissertation, Bilkent University, Ankara, Turkey). 
http://repository.bilkent.edu.tr/handle/11693/28963 URI: http://hdl.handle.net/11693/28963

11. - Federico Martínez-Ramos, Yadira Fonseca-Sabater, Marvin A. Soriano-Ursúa, Eduardo Torres, Martha C. Rosales-Hernández MC, José G. Trujillo-Ferrara, Luis E. Tolentino-Lopez, Ilizaliturri-Flores Ian and José Correa-Basurto. Alkylselenenylated benzoic acid accesses several sites in serum albumin according to fluorescence studies, Raman spectroscopy and theoretical simulations.   Protein Pept Lett. 2013;20(6):705-14.

(86) 1.         B.   Martiniano Bello, Marlet Martínez-Archundia & José Correa-Basurto. Automated docking for novel drug discovery. Exp Opin Drug Discov. 2013, 8 (7):821-834.

(87) 2.         B. Mónica Griselda Arellano-Mendoza, José Correa-Basurto, María Elena Hernández-Campos, Hulme Ríos-Guerra, Archundia-Martínez M and Ignacio Valencia-Hernández. Quinpirole-Induced Vasodilation Via Activation Of Rat Α2d Adrenergic. DovePress, 2014.

(88) 3.         A. DA Antunes, D Devaurs, LE Kavraki.  Understanding the challenges of protein flexibility in drug design. Expert Opin Drug Design. 2015. DOI: 10.1517/17460441.2015.1094458

(89) 4.         A. Rocha JBT, Piccoli B, Oliveira CS. Biological and chemical interest in selenium: a brief historical account. Archive for Organic Chemistry (Arkivoc). 2017. II:457-491. http://dx.doi.org/10.3998/ark.5550190.p009.784

(90) 5.         A. Sulimov AV, Zheltkov DA, Oferkin IV, Kutov DC, KAtkova EV, Tyrtyshnikov EE, Sulimov VB. Evaluation of the novel algorithm of flexible ligand docking with moveable target-protein atoms. Comput Struct Bio J. 2017. doi:10.1016/j.csbj.2017.02.004

(91) 6.         A. Devaurs, D., Antunes, D. A., Hall-Swan, S., Mitchell, N., Moll, M., Lizée, G., & Kavraki, L. E. (2019). Using parallelized incremental meta-docking can solve the conformational sampling issue when docking large ligands to proteins. BMC molecular and cell biology, 20(1), 1-15.

12. – Marvin A. Soriano-Ursúa*, José G. Trujillo-Ferrara, José Correa-Basurto, Santiago Vilar. Recent structural advances of beta1 and beta2 adrenoceptors yield keys for ligand recognition and drug design. J Med Chem. 2013. 56:8207–8223. DOI: 10.1021/jm400471z.

(92) 1. A. Tian-Shi Feng, Zhi-Yi Yuan, Run-Qing Yang, Shuang Zhao, Fan Lei, Xin-Yue Xiao, Dong-Ming Xing, Wei-Hua Wang, Yi Ding, Li-Jun Du,Purgative components in rhubarbs: Adrenergic receptor inhibitors linked with glucose carriers. Fitoterapia. 2013, 91:236-246.

(93) 2. A. Procopiou PA, et al. The discovery of a rapidly-metabolized, long-acting β2 adrenergic receptor agonist with a short onset-time incorporating a sulfone group suitable for once-daily dosing. J Med Chem. 2013, 57(1):159-170.  

(94) 3. A. Rose AS, et al. Position of Transmembrane Helix 6 Determines Receptor G Protein Coupling Specificity. J Am Chem Soc, 2014, 136 (32):11244–11247.

(95) 4. A. Zhu Y, Yuan Y, Xiao X, Zhang L, Guo Y, Pu X. Understanding the effects on constitutive activation

and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation. J Mol Model. 2014, 20:2491. DOI: 10.1007/s00894-014-2491-2.

(96) 5.   B. Méndez-Luna D, Martínez-Archundia M, Maroun RC, Ceballos-Reyes G, Fragoso-Estevez MJ, González-Juárez DE, Correa-Basurto J. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations. Journal of Biomolecular Structure and Dynamics. 2015,92:672-681. Doi: 10.1080/07391102.2014.994102.

(97) 6.    A.Angelone T, Caruso A, Rochais C, Caputo AM, Cerra MC, Dallemagne P, Filice E, Genest D, Pasqua T, Puoci F, Saturnino C, Sinicropi MS, El-Kashef H. Indenopyrazole oxime ethers: Synthesis and β₁-adrenergic blocking activity Eur J Med Chem. 2015. Doi: 10.1016/j.ejmech.2015.01.037.

(98) 7.  A. Santiago Rios, Marta F. Fernandez, Gianluigi Caltabiano, Mercedes Campillo, Leonardo Pardo and Angel Gonzalez. GPCRtm: An amino acid substitution matrix for the transmembrane region of class A G Protein-Coupled Receptors. BMC Bioinformatics. 2015, 16:206. doi:10.1186/s12859-015-0639-4.

(99) 8.   A. Tan DWS,Wong JL, Tie ST et al. β2-adrenoceptor in obstructive airway diseases: Agonism, antagonism or both? World J Respirol. 2015; 5(3): 199-206.

(100) 9.  A. Zhang Y, Zeng K, Wang J, Gao H, Nan Y, Zheng X. Identifying the antiasthmatic target of doxofylline using immobilized β₂ -adrenoceptor based high-performance affinity chromatography and site-directed molecular docking. J Mol Recognit. 2016. 29:492-8. doi:10.1002/jmr.2549.

(101) 10. A. Stocks M, Alcaraz L. Lead Generation Approaches Delivering Inhaled β2‐Adrenoreceptor Agonist Drug Candidates. En: Lead Generation: Methods, Strategies, and Cases studies, 2016. Wiley, DOI: 10.1002/9783527677047.ch20.

(102) 11.   A. Liu, G., Wang, P., Li, C., Wang, J., Sun, Z., Zhao, X., & Zheng, X. (2017). Confirming therapeutic target of protopine using immobilized β2‐adrenoceptor coupled with site‐directed molecular docking and the target‐drug interaction by frontal analysis and injection amount–dependent method. Journal of Molecular Recognition. 2017; 7:e2613. Doi:10.1002/jmr.2613

(103) 12.   A. Morise, Z., & Wakabayashi, G. (2017). First quarter century of laparoscopic liver resection. World Journal of Gastroenterology, 23(20), 3581.

(104) 13.   A. Sun, Z., Wang, J., Li, Q., Zhao, M., Zhang, Y., Xiong, X., ... & Zheng, X. A fast affinity extraction methodology for rapid screening of bioactive compounds specifically binding to beta2-adrenergic receptor from Xie-Bai-San. Medicinal Chemistry Research, 2017; 26(10):2410-2419.

(105) 14.   A. Soave, M., Cseke, G., Hutchings, C. J., Brown, A. J., Woolard, J., & Hill, S. J. (2018). A monoclonal antibody raised against a thermo-stabilised β 1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β 1-adrenoceptors expressed in stable cell lines. Biochemical Pharmacology. 147, 38-54.

(106) 15.  A. Fretter, Y. (2016). Biochemische und biophysikalische Charakterisierung von G‐Protein‐gekoppelten Rezeptoren= Biochemical and biophysical characterization of G protein‐coupled receptors. Doctoral thesis. Bochum, Germany.urn:nbn:de:hbz:294-51309 
https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/year/2017/docId/5130

(107) 16.  A. Wang, J., Li, F., Zeng, K., Li, Q., Zhao, X., & Zheng, X. (2017). Bioactive compounds of Shuang–Huang–Lian prescription and an insight into its binding mechanism by β2‐adrenoceptor chromatography coupled with site‐directed molecular docking. Journal of Separation Science.  40(22), 4357-4365.

(108) 17.  A. Kooistra, A. J., Leurs, R., De Esch, I. J., & de Graaf, C. (2015). Structure-based prediction of G-protein-coupled receptor ligand function: a β-adrenoceptor case study. Journal of chemical information and modeling, 55(5), 1045-1061.

(109) 18.  B. Vilar, S., Sobarzo-Sanchez, E., Santana, L., & Uriarte, E. (2017). Molecular docking and drug discovery in β-adrenergic receptors. Current medicinal chemistry, 24(39), 4340-4359

(110) 19. A. Tan, Daniel WS, et al. "β_2-adrenoceptor in obstructive airway diseases: Agonism, antagonism or both?." World 3 (2015): 003.

(111) 20.   A. Liu, T., Hou, Y., Liu, J., Li, Q., Wang, J., Liang, Y., ... & Zhao, X. (2018). Screening bioactive compounds with multi-targets from Rhodiola crenulata by a single column containing co-immobilized beta2-adrenergic receptor and voltage dependent anion channel isoform 1. Journal of Chromatography B, 1100, 76-82.

(112) 21.  A. Fei, F., Sun, H., Cheng, X., Liu, J., Wang, J., Li, Q., & Zhang, Y. (2018). Rapid screening and identification of bioactive compounds specifically binding to beta 2-adrenoceptor from San-ao decoction using affinity magnetic fine particles coupled with high-performance liquid chromatography–mass spectrometry. Chinese Medicine, 13(1), 49

13.- Soriano-Ursúa MA*, McNaught-Flores DA, Nieto-Alamilla G, Segura-Cabrera A, Correa-Basurto J, Arias-Montaño JA, Trujillo-Ferrara JG. Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human 2-adrenoceptor. Bioorg Med Chem. 2012, 20: 933–941.

(113) 1. B. Angélica Osorio-Espinoza, Juan Escamilla-Sánchez, Guillermo Aquino-Jarquin, José-Antonio Arias-Montaño. Homologous desensitization of human histamine H3receptors expressed in CHO-K1 cells. Neuropharmacology, 2014, 77:387-397.

(114) 2. A. Congreve M, Dias JM, Marshall FH. Structure Based Drug Design for GPCR. Progress in Medicinal Chemistry. 2014, 53:1-63.

(115) 3. B. Albert J. Kooistra, Henry F. Vischer, Daniel McNaught-Flores, Rob Leurs, Iwan J. P. de Esch & Chris de Graaf.   Function-specific virtual screening for GPCR ligands using a combined scoring method. Scientific Reports 6:28288 (2016) doi:10.1038/srep28288.

(116) 4. A. Acher, F., Battaglia, G., Bräuner-Osborne, H., Conn, P. J., Duvoisin, R., Ferraguti, F., ... & Johnson, M. P. (2019). Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE, 2019(4).

14. Amezcua-Gutiérrez MA, Ciprés-Flores FJ, Trujillo-Ferrara JG, Soriano-Ursúa MA*. Clinical implications of recent insights into the structural biology of beta2 adrenoceptor.  Current Drug Targets. 2012, 13(10):1336-46.

(117) 1.     A. YUAN Ming, LI Cheng, GUO Wen-yi, LI Cheng-xiang, WANG Hai-chang. Northwest Han patients with essential hypertension β2 adrenergic Receptor polymorphisms on hardening of the arteries and ventricular remodeling. Chin J Clinicians (Electronic Edition), 2013, 7(22):1-6.

(118) 2.    A. YUAN Ming, LI Cheng, GUO Wen-yi, LI. Genetic influences of β2 adrenoceptor polymorphisms on arterial functional changes and cardiac remodeling in hypertensive patients with northwest han nationality. Chin J Clinicians (Electronic Edition), 2013, 7(22):9890-9893. Cheng-xiang, WANG Hai-chang.Department of Cardiology, Xijing Hospital, Xi'an 710032，China.

(119) 3.    A. Tan DWS,Wong JL, Tie ST et al. β2-adrenoceptor in obstructive airway diseases: Agonism, antagonism or both? World J Respirol. 2015; 5(3): 199-206.

(120) 4.    A. Brucker MC and King TL. Pharmacology of women’s health. 2 Ed. ISBN 978-443-5000. JB Learning, 2016. Chapter 2, Pag.48. USA.

(121) 5.    A. Nojiri, M., Mizuno, S., Nishiki, K., Kato, R., Nakagawa, K., Oikawa, T., ... & Toga, H. (2018). ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema. Pulmonary pharmacology & therapeutics, 48, 80-87.

15. Soriano-Ursúa MA*, Farfán-García ED, López-Cabrera Y, Querejeta E, Trujillo-Ferrara JG. Boron-containing acids: Preliminary evaluation of acute toxicity and access to the brain determined by Raman scattering spectroscopy. NeuroToxicology. 2014; 40:8-15.

(122) 1. A. Reix N, Moreau F, Spizzo, AH, Canel C, Catargi B, Sigrist S, Jeandidier N. Les insulines intelligentes: une nouvelle forme de pancréas artificiel. Médecine des maladies Métaboliques. 2014, 8(2):141-146.

(123) 2. A. Liu CT, Tomsho JW, Benkovic SJ. The Unique Chemistry of Benzoxaboroles: Current and Emerging Applications in Biotechnology and Therapeutic Treatments. Bioorg. Med. Chem, 2014, 16:4462-4473.

(124) 3. A.  H Scott, RM Walmsley. Ames positive boronic acids are not all eukaryotic genotoxins. - Mutation Research/Genetic Toxicology and Env Mut, 2014, Doi: doi:10.1016/j.mrgentox.2014.12.002.

(125) 4. A. Hopfl H, Hernandez-Paredes J, Olvera-Tapia AL, Arenas-Garcia JI, Morales-Rojas H, Herrera-Ruiz D, Gonzaga-Morales AI and Rodriguez-Fragoso L. On molecular complexes derived from amino acids and nicotinamides in combination with boronic acids. Cryst. Eng. Comm. 2015, 17: 5166-86. DOI: 10.1039/C4CE01934B.

(126) 5. A. PA Nistor, PW May, F Tamagnini, AD Randall, Caldwell MA. Long-term culture of pluripotent stem-cell-derived human neurons on diamond–A substrate for neurodegeneration research and therapy. Biomaterials 2015; 61: 139-149.

(127) 6. A. Patrick R. Durkin. SERA TR-056-15-03c Sporax® and Cellu-Treat® (Selected Borate Salts) Human Health and Ecological Risk Assessment.  FINAL REPORT Syracuse Environmental Research Associates, Inc.  8125 Solomon Seal Manlius, New York 13104

(128) 7. A. Culhaoglu AK, Özcan E, Kilicarslan MA, Seker E. Effect of Boric Acid Versus Conventional Irrigation Solutions on the Bond Strength Between Fiber Post and Root Dentin. J Adhes Dent. 2017;19(2):137-146. doi: 10.3290/j.jad.a38143.

(129) 8. A. Wu, J. Z., Williams, G. R., Li, H. Y., Wang, D. X., Li, S. D., & Zhu, L. M. Insulin-loaded PLGA microspheres for glucose-responsive release. Drug Delivery, 2017; 24(1), 1513-1525.

(130) 9. A. Khalil, A. M., Salman, W. K., & Al-Qaoud, K. M. (2017). Evaluation of Genotoxic Potential of 2-(Bromoacetamido) Phenylboronic Acid on Balb/C Mice Peripheral Blood Cells Using In Vivo Micronucleus Assay. Jordan Journal of Pharmaceutical Sciences, 10(2).

(131) 10. A. Marasovic, M., Ivankovic, S., Stojkovic, R., Djermic, D., Galic, B., & Milos, M. (2017). In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 1299-1304.

(132) 11. A. Khaliq, H., Juming, Z., & Ke-Mei, P. (2018). The Physiological Role of Boron on Health. Biological trace element research, 186:31-51.

(133) 12. A. Zhang, X., Xu, G., Gadora, K., Cheng, H., Peng, J., Ma, Y., ... & Ding, Y. (2018). Dual-sensitive chitosan derivative micelles for site-specific drug release in the treatment of chicken coccidiosis. RSC Advances, 8(26), 14515-14526.

(134) 13. A. Tang, J., Zheng, X. T., Xiao, K., Wang, K. L., Wang, J., Wang, Y. X., ... & Sun, P. P. (2016). Effect of boric acid supplementation on the expression of BDNF in African ostrich chick brain. Biological trace element research, 170(1), 208-215

(135) 14. A. Deeg, K., Gima, Z., Smith, A., Stoica, O., & Tran, K. Greener Solutions: Improving performance of mycelium-based leather. https://bcgctest.files.wordpress.com/2018/03/gs_2017_mycoworks_finalreport.pdf

(136) 15. A Baldwin, A. F., North, R., & Eisenbeis, S. (2019). Trace Level Quantification of Derivatized Boronic Acids by LC/MS/MS. Organic Process Research & Development, 23(1), 88-92

(137) 16.A Zegota, M. M., Wang, T., Seidler, C., Wah Ng, D. Y., Kuan, S. L., & Weil, T. (2018). “Tag and Modify” Protein Conjugation with Dynamic Covalent Chemistry. Bioconjugate chemistry, 29(8), 2665-2670.

(138) 17.A Zhang, X., Xu, G., Gadora, K., Cheng, H., Peng, J., Ma, Y., ... & Ding, Y. (2018). Dual-sensitive chitosan derivative micelles for site-specific drug release in the treatment of chicken coccidiosis. RSC Advances, 8(26), 14515-14526.

(139) 18.A Беккер, Р. А., & Быков, Ю. В. (2018). BORON DRUGS IN PSYCHIATRY AND NEUROLOGY: 

THEIR RISING, DROP AND RESUMPTION OF INTEREST. Acta Biomedica Scientifica, 3(4), 85-100. 

https://doi.org/10.29413/ABS.2018-3.4.13

(140) 19. A. Baldwin, A. F., North, R., & Eisenbeis, S. (2019). Trace Level Quantification of Derivatized 

Boronic Acids by LC/MS/MS. Organic Process Research & Development, 23(1), 88-92.

16. Soriano-Ursúa MA*, Das B, Trujillo-Ferrara JG. Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy. Expert Opinion on Therapeutics Patents. 2014; 24(5):485-500.

(141) 1. A. Nicolas P. E. Barry*, Anaïs Pitto-Barry, Isolda Romero-Canelón, Johanna Tran, Joan J. Soldevila-Barreda, Ian Hands-Portman, Corinne J. Smith, Nigel Kirby, Andrew P. Dove, Rachel K. O'Reilly and Peter J. Sadler. Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity. Faraday Discuss. 2014. 175:229-40. DOI: 10.1039/C4FD00098F.

(142) 2. A. Chellan P, Sadler PJ. The elements of life and medicine. Phylosophical transactions A. 2015. 373(2037): 20140182. DOI: 10.1098/rsta.2014.0182

(143) 3. A. M. Chinnapattu, K. I. Sathiyanarayanan and P. S. Iyer, RSC Adv., 2015, DOI: 10.1039/C5RA05082K.

(144) 4. A. Cornier K, Curry RD, Betsch MP, Goguen JA, Vogels CM, Decken A, Turcotte S, Westcott SA. Synthesis, Characterization, and Anticancer Activities of Pyrogallol-Based Arylspiroborates. J Heterocyclic Chem. 2016. 53(6):1807-12.  DOI 10.1002/jhet.2490.

(145) 5. A. R Trivedi, RR Eda, SVS Akella, S Balasubramanian. Sugar-boronate ester scaffold tethered pyridyl-imine palladium (II) complexes: Synthesis and their in vitro anticancer evaluation. Dalton transactions. 2015. 44(40):17600-16. Doi:  10.1039/C5DT03266K.

(146) 6. A. Patterson AE, Flewelling AJ, Clark TN, Geier SJ, Vogels CM, Masuda J, Gray C, Westcott SA. Anti-microbial and anti-mycobacterial activities of aliphatic amines derived from vanillin. Canadian Journal of Chemistry, 2015,2015, 93(11): 1305-1311. Doi: 10.1139/cjc-2015-0400.

(147) 7. A. Jinna S, Finch J.  Spotlight on tavaborole for the treatment of onychomycosis. Drug Des Devel. 2015; 9:6185-6190.

(148) 8. A. Morera E, Di Marzo V, Monti L, et al. Arylboronic acids as dual-action FAAH and TRPV1 ligands. Bioorg Med Chem Lett 26 (2016) 1401–1405.

(149) 9. A. Behnam MA, Sundermann RT, Klein CD. Solid Phase Synthesis of C-Terminal Boronic Acid Peptides. Org. Lett., 2016, 18 (9): 2016–2019.

(150) 10. A. ER Reddy, R Trivedi, BS Kumar, K Sirisha, AVS Sarma. Synthesis, characterization and antimicrobial activity of novel Schiff base tethered boronate esters of 1, 2-O-isopropylidene-α-D-xylofuranose. Bioorg Med Chem Lett. 26(15):3447-3452. doi:10.1016/j.bmcl.2016.06.049

(151) 11. A. PD St-Coeur, S Kinley, CM Vogels, et al. Synthesis, characterization, and anticancer properties of iminophosphineplatinum (II) complexes containing boronate esters. Canadian J Chem. 2017. 95(2): 207-213. Doi: 10.1139/cjc-2016-0570.

(152) 12. A. Bolt HM, Duydu Y, Basaran N, Golka K. Boron and its compounds: current biological research activities. Arch Toxicol. 2017; 91(8):2719-2722. DOI 10.1007/s00204-017-2010.

(153) 13. A. Yang, F., Zhu, M., Zhang, J., & Zhou, H. (2017). Synthesis of Biologically Active Boron-Containing Compounds. MedChemComm. 10.1039/C7MD00552K

(154) 14. A. Zhu, D., Hunter, C. D., Baird, S. R., Davis, B. R., Bos, A., Geier, S. J., ... & Westcott, S. A. (2017). Synthesis and antimicrobial properties of cyclic fluorodiamines containing boronate esters. Heteroatom Chemistry. 28(6): e21405.

(155) 15. B. Akgul, A., Al-Janabi, N., Das, B., Lawrence, M., & Karsi, A. (2017). Small molecules targeting LapB protein prevent Listeria attachment to catfish muscle. PloS one, 12(12).

(156) 16. A. Yang, F., Zhu, M., Zhang, J., & Zhou, H. (2018). Synthesis of biologically active boron-containing compounds. MedChemComm. 2018,9, 201-211.

(157) 17. A. Gumienna‐Kontecka, E., Rowińska‐Żyrek, M., & Łuczkowski, M. (2018). The Role of Trace Elements in Living Organisms. Recent Advances in Trace Elements, 177. https://doi.org/10.1002/9781119133780.ch9 Print ISBN: 9781119133773 Wiley

(158) 18. A. Hoang, G. L., Zhang, S., & Takacs, J. M. (2018). Rhodium-catalyzed asymmetric hydroboration of γ, δ-unsaturated amide derivatives: δ-borylated amides. Chemical Communications.

(159) 19. A. Janetková, M. (2018). Využití HPLC v chirálních separacích III. PhD Thesis. Univerzita Karlova, Farmaceutická fakulta v Hradci Králové. http://hdl.handle.net/20.500.11956/91789

(160) 20. A. Galliamova, L. A., Varaksin, M. V., Chupakhin, O. N., Slepukhin, P. A., & Charushin, V. N. (2015). Heterocyclic and Open-Chain Carboranes via Transition-Metal-Free C–H Functionalization of Mono-and Diazine-N-oxides. Organometallics, 34(21), 5285-5290.

(161) 21. A. Donoiu, I., Militaru, C., Obleagă, O., Hunter, J. M., Neamţu, J., Biţă, A., ... & Rogoveanu, O. C. (2018). Effects of Boron-Containing Compounds on Cardiovascular Disease Risk Factors–A Review. Journal of Trace Elements in Medicine and Biology, 50, 47-56.

(162) 22. A. Cormier, K., Curry, R. D., Betsch, M. P., Goguen, J. A., Vogels, C. M., Decken, A., ... & Westcott, S. A. (2016). Synthesis, Characterization, and Anticancer Activities of Pyrogallol‐Based Arylspiroborates. Journal of Heterocyclic Chemistry, 53(6), 1807-1812

(163) 23. A. Bellomo, C., Chaari, M., Cabrera‐González, J., Blangetti, M., Lombardi, C., Deagostino, A., ... & Prandi, C. (2018). Carborane‐BODIPY Dyads: New Photoluminescent Materials through an Efficient Heck Coupling. Chemistry–A European Journal, 24(58), 15622-15630.

(164) 24. A. Soor, H. S., Hansen, J., Diaz, D. B., Appavoo, S., & Yudin, A. K. (2019). Solid‐phase synthesis of peptide β‐aminoboronic acids. Peptide Science, 111(1), e24072.

(165) 25. A. Hunter, J. M., Nemzer, B. V., Rangavajla, N., Biţă, A., Rogoveanu, O. C., Neamţu, J., ... & Mogoşanu, G. D. (2019). The Fructoborates: Part of a Family of Naturally Occurring Sugar–Borate Complexes—Biochemistry, Physiology, and Impact on Human Health: a Review. Biological trace element research, 188(1), 11-25.

(166) 26. A. Ma, P., Pellizzeri, T. M. S., Zubieta, J., & Spencer, J. T. (2018). Synthesis and Characterization of Oxonium Functionalized Rhenium Metallaborane. Journal of Chemical Crystallography, 1-7. Doi: 10.1007/s10870-018-0749-8

(167) 27. A. Jankowska, A., Świerczek, A., Wyska, E., Gawalska, A., Bucki, A., Pawłowski, M., & Chłoń-Rzepa, G. (2019). Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research. Current drug targets, 20(1), 122-143

(168) 28. A. Smyshlyaeva, L. A. (2018). С-H / C-Li combinations of N-oxides with carboranyl in the synthesis of 

new boron-enriched aza-heterocyclic derivatives: dissertation for the degree of Candidate of Chemical Sciences

(Doctoral dissertation, Ural Federal University, Russia). http://elar.urfu.ru/bitstream/10995/63751/1/urfu1878_d.pdf

(169) 29. A. Viñas, C., Núñez, R., Bennour, I., & Teixidor, F. (2019). Periphery Decorated and Core Initiated Neutral 

and Polyanionic Borane Large Molecules: Forthcoming and Promising Properties for Medicinal Applications. Current medicinal chemistry. https://doi.org/10.2174/0929867326666190603123838

  

17. Farfán-García Eunice D., Trujillo-Ferrara José G., Castillo-Hernández María C., Guerra-Araiza Christian H., Soriano-Ursúa Marvin A*. Insights into the structural biology of GPCRs impacts drug design for CNS neurodegenerative processes. Neural Regeneration Res. 2013. 8(24): 2290-2302.

(170) 1. A. M. Teresa Miras-Portugal, Juan I. Diaz-Hernandez, Rosa Gomez-Villafuertes, Miguel Diaz-Hernandez, Antonio R. Artalejo, Javier Gualix. Role of P2X7 and P2Y2 receptors on α-secretase-dependent APP processing: Control of amyloid plaques formation “in vivo” by P2X7 receptor, Computational and Structural Biotechnology Journal. 2015. 13:176-181. Doi:10.1016/j.csbj.2015.02.005.

(171) 2. A. Hopper S, Udawela M, Scarr E, Dean B. Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia. World J Pharm. 2016. 5:32-43.

(172) 3. A. Lütjens R, Rocher JP. Recent Advances in drug discovery of GPCR allosteric modulators for neurodegenerative diseases. Current Opin Pharm. 2017.

(173) 4. A. Saxena, A. K., Bhunia, S. S., & Saxena, M. (2017). Integration on Ligand and Structure Based Approaches in GPCRs. Topics in medicinal chemistry. In: Lebon G. (eds) Structure and Function of GPCRs. Topics in Medicinal Chemistry, vol 30. Springer, Cham. Doi: /10.1007/7355_2016_24.

(174) 5. A. Kim, H., & Han, H. (2018). Computer-Aided Multi-Target Management of Emergent Alzheimer’s Disease. Bioinformation, 14(4), 167-180

(175) 6. A. Cacciari, B., Spalluto, G., & Federico, S. (2018). A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?. Mini reviews in medicinal chemistry, 18(14), 1168-1174.

(176) 7. A. León-Navarro, D. A., Albasanz, J. L., & Martín, M. (2019). Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors. Current neuropharmacology, 17(5), 422-437.

18. Castro JJ, Méndez JP, Coral-Vázquez RM, Soriano-Ursúa MA, Damian-Matsumura P, Benítez JG, Rosas-Vargas H and Canto P. In Vitro And Molecular Modeling Analysis Of Two Mutant Desert Hedgehog (Dhh) Proteins Associated With 46,Xy Gonadal Dysgenesis. DNA and Cell Biology. 2013; 32(9):524-30.

(177) 1. A. Ralf Werner, Hartmut Merz, Wiebke Birnbaum, Louise Marshall, Tatjana Schröder, Benedikt Reiz, Jennifer M. Kavran, Tobias Bäumer, Philipp Capetian, and Olaf Hiort. 46, XY Gonadal Dysgenesis due to a Homozygous Mutation in Desert Hedgehog (DHH) Identified by Exome-Sequencing. J Clin End Met. 2015. Doi: 10.1210/jc.2015-1314.

(178) 2. A. Whilhelm D, et al. Genes and Gene Defects Affecting Gonad Development and Primary Sex Determination. Ref. Modul. Biomed Sci. 2015. DOI: 10.1016/B978-0-12-801238-3.06072-4

(179) 3. A. Milunski A. Prenatal Diagnosis of Sex Cromosomal Abnormalities. 7 Ed. 2016. John And Wiley sons.

(180) 4. A. GÜL Ülkü, D ÖKDEMİR, NF ARAS, et al.  Nadir Bir Kuşkulu Genitalya Nedeni: Mikst Gonadal Disgenezis. Turkiye Klinikleri J Case Rep 2016;24(Suppl):S26-S29.

(181) 5. A. Sato, N. S., Maekawa, R., Ishiura, H., Mitsui, J., Naruse, H., Tokushige, S.-i., Sugie, K., Tate, G., Shimizu, J., Goto, J., Tsuji, S. and Shiio, Y. (2017), Partial duplication of DHH causes minifascicular neuropathy. Ann Clin Transl Neurol. doi:10.1002/acn3.417

(182) 6. A. Hyon C. Etude des gènes impliqués dans le déterminisme gonadique chez l'homme. 2016. Génétique humaine. Universite Pierre et Marie Curie - Paris VI, 2016. HAL Id: tel-01539508.

(183) 7. A. Mäkelä, J. A., & Toppari, J. (2017). Spermatogenesis 13. Endocrinology of the Testis and Male Reproduction (book), 1, 417. In: Simoni, Manuela, and Ilpo T. Huhtaniemi, eds. Springer, 2017. https://doi.org/10.1007/978-3-319-44441-3. ISBN: 978-3-319-44440-6

(184) 8. A. Alimussina, M., Diver, L. A., McGowan, R., & Ahmed, S. F. (2018). Genetic testing of XY newborns with a suspected disorder of sex development. Current opinion in pediatrics, 30(4), 548-557.

19. Madrigal-Santillán E, Bautista M, Gayosso-de-Lucio JA, Reyes-Rosales Y, Posadas-Mondragon A, Morales-González A, Soriano-Ursúa MA, García-Machorro J, Madrigal-Bujaidar E, Álvarez-González I, Morales-González JA. Hepatoprotective effect of Geranium schiedeanum against ethanol toxicity during liver regeneration.  World J Gastroenterol. 2015. ISSN: 1007-9327.

(185) 1. B. José A. Morales-González, Eduardo Madrigal-Santillán, Ángel Morales-González, Mirandeli Bautista, Evila Gayosso-Islas and Cecilia Sánchez-Moreno. What is Known Regarding the Participation of Factor Nrf-2 in Liver Regeneration? Cells 2015, 4(2), 169-177.

(186) 2. B. Bautista M; Madrigal-Santillán E; Morales-González Á; Gayosso-Delucio JA; Madrigal-Bujaidar E; Chamorro-Cevallos G; Álvarez-González I; Benedi J; Aguilar-Faisal JL, Morales-González JA. An alternative hepatoprotective and antioxidant agent: the geranium. African Ethnomedicines Network 2015; 12(4): 96-105.

(187) 3. A.  S Saha, K Rashid, P Sadhukhan, N Agarwal, PC Sil. Attenuative role of mangiferin in oxidative stress‐mediated liver dysfunction in arsenic‐intoxicated murines. - BioFactors, 2016.42(5):515-532.

(188) 4.A. Nancy Sayuri Uchida et al., Protective Effect of Cymbopogon citratus Essential Oil in Experimental Model of Acetaminophen-Induced Liver Injury. Am. J. Chin. Med. 0, 1(2017). 45(3):515-532.   DOI: http://dx.doi.org/10.1142/S0192415X17500318

(189) 5. A. Sharma, R., Sharma, A., Kumari, A. et al. Consumption of green tea epigallocatechin-3-gallate enhances systemic immune response, antioxidative capacity and HPA axis functions in aged male swiss albino mice

Biogerontology (2017). 18(3):367-382. doi:10.1007/s10522-017-9696-6.

(190) 6.     A. Uchida, N. S., Silva-Filho, S. E., Cardia, G. F. E., Cremer, E., Silva-Comar, F. M. D. S., Silva, E. L., ... & Cuman, R. K. N. (2017). Hepatoprotective Effect of Citral on Acetaminophen-Induced Liver Toxicity in Mice. Evidence-Based Complementary and Alternative Medicine, 2017:1796209. doi: 10.1155/2017/1796209.

(191) 7.     A. Basak, P., Sadhukhan, P., Sarkar, P., & Sil, P. C. (2017). Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy. Toxicology Reports. 4, 306-318.

(192) 8.      A. BISPO, V. S., DANTAS, L. S., CHAVES FILHO, A. B., PINTO, I. F., SILVA, R. P., OTSUKA, F. A., ... & MATOS, H. R. (2017). Reduction of the DNA damages, Hepatoprotective Effect and Antioxidant Potential of the Coconut Water, ascorbic and Caffeic Acids in Oxidative Stress Mediated by Ethanol. Anais da Academia Brasileira de Ciências, 2017; 89(2). doi: 10.1590/0001-3765201720160581 

(193) 9.     B. Bello, M., & Morales-González, J. A. (2017). Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex. International Journal of Biological Macromolecules. 105, 981-992.

(194) 10. B. Morales-Gonzalez, A., Bautista, M., Madrigal-Santillan, E., Posadas-Mondragon, A., Anguiano-Robledo, L., Madrigal-Bujaidar, E., ... & Morales-González, J. A. (2017). Nrf2 modulates cell proliferation and antioxidants defenses during liver regeneration induced by partial hepatectomy. International Journal Of Clinical And Experimental Pathology, 10(7), 7801-7811.

(195) 11.  B. Morales-González, J. A., de Lourdes Sernas-Morales, M., Morales-González, Á., González-López, L. L., Madrigal-Santillán, E. O., Vargas-Mendoza, N., ... & Chamorro-Cevallos, G. (2018). Morphological and biochemical effects of weekend alcohol consumption in rats: Role of concentration and gender. World Journal of Hepatology, 10(2), 297-307.

(196) 12. A. Chung, A. P., Gurtu, S., Chakravarthi, S., Moorthy, M., & Palanisamy, U. D. (2018). Geraniin Protects High-Fat Diet-Induced Oxidative Stress in Sprague Dawley Rats. Frontiers in nutrition, 5, 17.

(197) 13.           A. Basak, P., Sadhukhan, P., Sarkar, P., & Sil, P. C. (2017). Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy. Toxicology reports, 4, 306-318.

(198) 14.           A. OKAMURA, Y., ONO, H., & ONO, A. (2018). Evaluation of the Effects of Frequent Alcohol Administration on Liver Function in Partially Hepatectomized Rats: Serum Changes. Kawasaki Journal of Medical Welfare, 24(1), 17-25.

(199) 15.           A. Saha, P., Talukdar, A. D., Nath, R., SARKAR, S., Nahar, L., Sahu, J., & Choudhury, M. D. (2019). Role of natural phenolics in hepatoprotection: A mechanistic review and analysis of regulatory network of associated genes. Frontiers in pharmacology, 10, 509.

(200) 16.           A. Moorthy, M., Khoo, J. J., & Palanisamy, U. D. (2019). Acute oral toxicity of the ellagitannin geraniin and a geraniin-enriched extract from Nephelium lappaceum L rind in Sprague Dawley rats. Heliyon, 5(8), e02333.

20.  Segura-Cabrera A., García-Pérez CA, Ciprés-Flores FJ, Cuevas-Hernández RI, Trujillo-Ferrara JG, Correa-Basurto J, Soriano-Ursúa MA. Molecular dynamics simulations to explore the active/inactive conformers of guinea pig β2 adrenoceptor for selective agonists or antagonists design. Mol Simulation. 2014; 40(15):1244-54.

(201) 1. A. J Jakubík, EE El-Fakahany, V Doležal. Towards predictive docking at aminergic G-protein coupled receptors. Journal of Molecular Modeling. 2015. 21(11):284. DOI 10.1007/s00894-015-2824-9.

21. Ramírez-San Juan E, Soriano-Ursúa MA, Espinosa-Raya J, Correa-Basurto J,  Trujillo-Ferrara J,  Miranda-Ruvalcaba R,  Delgado-Reyes F, Gómez-Pliego R. Anticonvulsant effects of bis-1,4-dihydropyridines and the probable role of l-type calcium channels suggested by docking simulations. Med Chem Res. 2014; 23:5149-5159.

(202) 1. B. Escobedo R, Miranda R and Martínez J. Infrared Irradiation: Toward Green Chemistry, a Review. Int J Mol Sci, 2016. 17:453.

(203) 2. A. Tarek Fathy El-Moselhy, Peter Ayoub Sidhom, Eman Ahmed Esmat, Nageh Ahmed El-Mahdy. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers. Chem Pharm Bull. 2017; 65 (10) :893-903.

(204) 3. B. Cisneros, G. I. V., Perez, J. M. V., Borbolla, J. C., Gómez-Castro, C. Z., Nicolás-Vázquez, M. I., & Ruvalcaba, R. M. (2018). Theoretical study: Electronic structure and receptor interaction of four type bis-1, 4-dihydropyridine molecules. Computational and Theoretical Chemistry. 1123:102-110.

(205) 4. A. El-Moselhy, T. F., Sidhom, P. A., Esmat, E. A., & El-Mahdy, N. A. (2017). Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1, 4-Dihydropyridines as Calcium Channel Blockers. Chemical and Pharmaceutical Bulletin, 65(10), 893-903.

(206) 5. A. Jain, R., & Jain, A. (2018). Anticonvulsant effects of nimodipine alone and combination with phenytoin on MES induced seizures. International Journal of Basic & Clinical Pharmacology, 7(6), 1160-1163.

22. Luis C. Jimenez-Botello, Marvin A. Soriano-Ursúa, Omar Deeb, Aldo Segura-Cabrera, M Martínez-Archundia and J Correa-Basurto. Homology modeling, molecular dynamics and docking simulations of rat A2A receptor, a three-dimensional model validate under QSAR studies.  Curr Trends Med Chem (ISSN: 0973-0532) 2013. 2013.7:35-52.

(207) 1. B. Omar Deeb, Heidy Martínez-Pachecho, Guillermo Ramírez-Galicia and Ramón Garduño-Juárez.  Application of Docking Methodologies in QSAR-Based Studies. Applied Case Studies and Solutions in Molecular Docking-Based Drug Design(book). Copyright: © 2016,  Page:27. IGI global, DOI: 10.4018/978-1-5225-0362-0.ch002

(208) 2. B. Hernández-Rodríguez, M., C Rosales-Hernández, M., E Mendieta-Wejebe, J., Martínez-Archundia, M., & Correa Basurto, J. (2016). Current tools and methods in molecular dynamics (MD) simulations for drug design. Current medicinal chemistry, 23(34), 3909-3924

(209) 3. A. Sehgal, S. A., Hammad, M. A., Tahir, R. A., Akram, H. N., & Ahmad, F. (2018). Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design. Current Neuropharmacology, 16(6), 649-663.

23. Marvin A. Soriano-Ursúa*, José G. Trujillo-Ferrara, José A. Arias-Montaño, Rafael Villalobos-Molina. Insights into a defined secondary binding region on β-adrenoceptors and putative roles in ligand binding and drug design. Med Chem Comm. 2015, 6:991-1002. ISSN:2040-2503. DOI: 10.1039/C5MD00011D.

(210) 1. A. Fronik P, Gaiser BI and Pedersen DS. Bitopic Ligands and Metastable Binding Sites: Opportunities for G

Protein-Coupled Receptor (GPCR) Medicinal Chemistry. J Med Chem. 2017, 60(10):4126-4134. 

(211) 2.         A. Fretter Y. Biochemische und biophysikalische Charakterisierung von G‐Protein‐gekoppelten Rezeptoren. Thesis. 2016. Bochum, Germany 2016.Doctoral thesis. Bochum, Germany.urn:nbn:de:hbz:294-51309  https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/year/2017/docId/5130

(212) 3.         A. Obeng, S., Wang, H., Jali, A., Stevens, D. L., Akbarali, H. I., Dewey, W. L., ... & Zhang, Y. (2018). Structure–Activity Relationship Studies of 6α-and 6β-Indolylacetamidonaltrexamine Derivatives as Bitopic Mu Opioid Receptor Modulators and Elaboration of the “Message-Address Concept” To Comprehend Their Functional Conversion. ACS chemical neuroscience. 10(3), 1075-1090.

24. Jímenez-Botello LC et al. The 1- metylxantine affinity for A2A adenosine receptors is similar to caffeine, theobromine, theophylline and adenosine. The importance of xanthine core. Parkinsonism Relat Disord 2016; 22: e100–e101.

(213) 1. A. Schmidt, J. and Ferk, P. (2017), Safety issues of compounds acting on adenosinergic signalling. J Pharm Pharmacol. 69(7), 790-806. doi:10.1111/jphp.12720

25. Ocampo-Néstor AL, Trujillo-Ferrara JG, Abad-García A, Reyes-López C, Geninatti-Crich S,  Soriano-Ursúa MA. Boron’s journey: Advances in the study and application of pharmacokinetics. Expert Opin Ther Patents 2017. 27(2):203-215.

(214) 1. A. Yudin, A. K., Kaldas, S. J., O'Keefe, K. T. V. and Rodrigo, M.-S. (2017), Amphoteric Borylketenimines: Versatile Intermediates in the Synthesis of Borylated Heterocycles. Chem. Eur. J. 23(41), 9711-9715. doi:10.1002/chem.201702008.

(215) 2. A. Kaldas, S. J., Rogova, T., Nenajdenko, V. G., & Yudin, A. K. (2018). Modular Synthesis of β-Amino Boronate Peptidomimetics. The Journal of Organic Chemistry. 83(13), 7296-7302.

26. Current data regarding the structure-toxicity relationship of boron-containing compounds. Farfán-García ED, Castillo-Mendieta NT, Ciprés-Flores FJ, Padilla-Martínez II, Trujillo-Ferrara JG and Soriano-Ursúa MA. Toxicology Letters. 2016. 258:115-125.

(216) 1. A. Bolt HM, Duydu Y, Basaran N, Golka K. Boron and its compounds: current biological research activities. Arch Toxicol. 2017; 91(8):2719-2722. DOI 10.1007/s00204-017-2010.

(217) 2. A. da Silva, M. B., Da Cunha, A. M., Santos, R. C. R., Valentini, A., Caetano, E. W. S., & Freire, V. N. (2017). Changing the gap type of solid state boric acid by heating: a dispersion-corrected density functional study of α-, β-, and γ-metaboric acid polymorphs. New Journal of Chemistry. 41(24), 15533-15544.

(218) 3. A. da Silva, M. B., Santos, R. C., Freire, P. T., Caetano, E. W., & Freire, V. N. (2018). Vibrational Properties of Bulk Boric Acid 2 A and 3 T Polymorphs and Their Two-Dimensional Layers: Measurements and Density Functional Theory Calculations. The Journal of Physical Chemistry A. 122(5), 1312-1325

(219) 4. A. Gumienna‐Kontecka, E., Rowińska‐Żyrek, M., & Łuczkowski, M. (2018). The Role of Trace Elements in Living Organisms. Recent Advances in Trace Elements, 177-206.

(220) 5. A. Durmuş, İ., İnce, S., Salim, M. N., Eryavuz, A., & Küçükkurt, İ. Gentamisin verilen sıçanlara bor uygulamasının hematolojik parametre düzeylerine etkileri. Kocatepe Veteriner Dergisi, 11(2), 140-147.

(221) 6. A. Janetková, M. (2018). Využití HPLC v chirálních separacích III. PhD Thesis. Univerzita Karlova, Farmaceutická fakulta v Hradci Králové. http://hdl.handle.net/20.500.11956/91789    

(222) 7. A. Rattanachaiwong, S., & Singer, P. (2015). Diets and Diet Therapy: Trace Elements.  In book: Reference Module in Food Science. Elsevier. Doi: 10.1016/B978-0-08-100596-5.21941-0

((223) 8.       A. Bezerra da Silva, M., Santos, R. C. R., Freire, P. T. C., Caetano, E. W. S., & Freire, V. N. (2018). Vibrational Properties of Bulk Boric Acid 2A and 3T Polymorphs and Their Two-Dimensional Layers: Measurements and Density Functional Theory Calculations. The Journal of Physical Chemistry A, 122(5), 1312-1325

(224) 9.         A. Stanić, V. (2019). Boron-Containing Bioactive Glasses for Bone Regeneration. In Biomedical, Therapeutic and Clinical Applications of Bioactive Glasses (pp. 219-249). Woodhead Publishing

(225) 10.     A. Jankowska, A., Świerczek, A., Wyska, E., Gawalska, A., Bucki, A., Pawłowski, M., & Chłoń-Rzepa, G. (2019). Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research. Current drug targets, 20(1), 122-143

(226) 11.      A. Беккер, Р. А., & Быков, Ю. В. (2018). Boron drugs in psychiatry and neurology: their rising, drop and resumption of

 interest. Acta Biomedica Scientifica, 3(4), 85-100.

(227) 12.      A. Chen, S., Cui, W., Hu, J., Guo, Y., & Deng, T. (2019). Phase Equilibria and Phase Diagrams for the Aqueous Ternary 

System Containing Sodium, Sulfate, and Metaborate Ions at 288.15 and 308.15 K and 101.325 kPa. Journal of Chemical & 

Engineering Data. 2019, 646:2809-2815.

(228) 13.      A. Yuan, Y., Chen, P., Zhang, S., Lan, X., Liu, Z., Wang, D., ... & Sun, X. (2019). Synthesis of polyunsaturated fatty 

boronic esters and their in vitro inhibition to HCT116 cell lines. Tetrahedron, 130578.

(229) 14.      Geyikoglu, F., Koc, K., Erol, H. S., Colak, S., Ayer, H., Jama, S., ... & Saglam, Y. S. (2019). The propolis and boric acid 

can be highly suitable, alone/or as a combinatory approach on ovary ischemia-reperfusion injury. Archives of Gynecology and 

Obstetrics, 1-8. Doi.org/10.1007/s00404-019-05303-9

(230) 15.      A. Chen, X., Su, L., Yin, X., & Pei, Y. (2019). Responses of Chlorella vulgaris exposed to boron: Mechanisms of toxicity

 assessed by multiple endpoints. Environmental toxicology and pharmacology, 70:103208.

(231) 16.      A. Jankowska, A., Świerczek, A., Wyska, E., Gawalska, A., Bucki, A., Pawłowski, M., & Chłoń-Rzepa, G. (2019). 

Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological 

Research. Current drug targets, 20(1), 122-143.

27. Farfán-García ED, Pérez-Rodríguez M, Espinosa-García C et al. (2016) Disruption of motor behavior and injury to the CNS induced by 3-thienylboronic acid in mice. Toxicol Appl Pharmacol 307:130–137.

(232) 1. B. Andrade-Jorge, E., Bahena-Herrera, J.R., Garcia-Gamez, J. et al. Med Chem Res (2017). 26(10), 2420-2431. doi:10.1007/s00044-017-1942-6.

28. Rocío M. Neri-Bazán, Jazmín García-Machorro, David Méndez-Luna, Luis E. Tolentino-López, Federico Martínez-Ramos, Itzia I. Padilla-Martínez, Leopoldo Aguilar-Faisal, Marvin A. Soriano-Ursúa, José G. Trujillo-Ferrara, M. Jonathan Fragoso-Vázquez, Blanca L. Barrón, José Correa-Basurto. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.  Eur J Med Chem. 2017. 128:154-167. http://dx.doi.org/10.1016/j.ejmech.2017.01.039.

(233) 1.   A. Li, Y., Lin, Z., Guo, M., Xia, Y., Zhao, M., Wang, C., ... & Zhu, B. Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus. International Journal of Nanomedicine, 2017; 12, 5733.

(234) 2.   A. Wang, K., Yang, F., Wang, L., Liu, K., Sun, L., Lin, B., ... & Tian, Y. (2017). Synthesis and biological evaluation of NH 2-acyl oseltamivir analogues as potent neuraminidase inhibitors. European Journal of Medicinal Chemistry. 2017, 141:648-656; Doi: 10.1016/j.ejmech.2017.10.004

(235) 3.   A. Liang, Z., & Li, Q. X. (2018). π-Cation Interactions in Molecular Recognition: Perspectives on Pharmaceuticals and Pesticides. Journal of agricultural and food chemistry. 66(13):3315-3323

(236) 4.         A. Ju, H., Zhang, J., Sun, Z., Huang, Z., Qi, W., Huang, B., ... & Liu, X. (2018). Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors. European journal of medicinal chemistry, 146, 220-231.

(237) 5.         A. Talevi, A. (2018). Drug repositioning: current approaches and their implications in the precision medicine era. Expert Review of Precision Medicine and Drug Development, 3(1), 49-61.

29. Osvaldo Garrido-Acosta, Sergio E. Meza-Toledo, Liliana Anguiano-Robledo, et al., “Anticonvulsant and Toxicological Evaluation of Parafluorinated/Chlorinated Derivatives of 3-Hydroxy-3-ethyl-3-phenylpropionamide,” BioMed Research International, vol. 2016, Article ID 3978010, 10 pages, 2016. doi:10.1155/2016/3978010

(238) 1.A. Zadorozhnii, P. V., Kiselev, V. V., Pokotylo, I. O., Okhtina, O. V., & Kharchenko, A. V. In silico prediction of anticonvulsant activity of N-(2, 2, 2-trichloro-1-hydroxyethyl) alkylcarboxamides.  Journal of Chemical and Pharmaceutical Sciences. 10, 1099-1105.

(239) 2.A. Sharma, D., Singh, A., Verma, K., Paliwal, S., Sharma, S., & Dwivedi, J. (2017). Fluoride: A Review of Pre-clinical and Clinical Studies. Environmental Toxicology and Pharmacology. 56, 297-313.

30. Marvin A. Soriano-Ursúa^*, José A. Arias-Montaño, José Correa-Basurto, Christian F. Hernández-Martínez, Yessica López-Cabrera, Maria C. Castillo-Hernández, Itzia I. Padilla-Martínez, José G. Trujillo-Ferrara. Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the beta2 adrenoceptor.^. Bioorg Med Chem Lett. 2015; 25(4):820-5.

(240) 1.A.  Fretter Y. Biochemische und biophysikalische Charakterisierung von G‐Protein‐gekoppelten Rezeptoren. Thesis. 2016. Bochum, Germany 2016.Doctoral thesis. Bochum, Germany.urn:nbn:de:hbz:294-51309 urn:nbn:de:hbz:294-51309   https://hss-opus.ub.ruhr-uni-bochum.de/opus4/frontdoor/index/index/year/2017/docId/5130

31. Mendez JP, Zenteno JC, Coronel A, Soriano-Ursúa MA, Valencia-Villalvazo EY, Soderlund D, Coral-Vazquez RM, Canto P. Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with –normosmic congenital hypogonadotropic hypogonadism. Endocrine Res. (ISSN: 0743-5800) 2015;40(3):166-71. DOI: 10.3109/07435800.2014.982327.

(241) 1. A. Umair, M., Seidel, H., Ahmed, I., Ullah, A., Haack, T. B., Alhaddad, B., ... & Meitinger, T. (2017). Ellis–van Creveld syndrome and profound deafness resulted by sequence variants in the EVC/EVC2 and TMC1 genes. Journal of Genetics, 96(6), 1005-1014.

(242) 2. A. Nair, P., Lama, M., El-Hayek, S., Sleymane, G. A., Stora, S., Obeid, M., ... & Mégarbané, A. (2018). COQ8A and MED25 mutations in a child with intellectual disability, microcephaly, seizures, and spastic ataxia: synergistic effect of digenic variants. Molecular syndromology, 9(6), 319-323.

(243) 3. A. Taroc, E. Z. M., Naik, A., Lin, J. M., Peterson, N. B., Keefe, D. L., Genis, E., ... & Forni, P. E. (2019). Gli3 regulates vomeronasal neurogenesis, olfactory ensheathing cell formation and GnRH-1 neuronal migration. BioRxiv, 643155.

(244) 4. A. Taroc, E. Z. M., Naik, A., Lin, J. M., Peterson, N. B., Keefe, D., Genis, E., ... & Forni, P. E. (2019). Gli3 loss-of-function compromises vomeronasal neurogenesis, formation of olfactory ensheathing cells in the nasal mucosa, and GnRH-1 neuronal migration. BioRxiv, 643155.

32. Rodolfo Pinto-Almazan, Julia J Segura-Uribe, Marvin A Soriano-Ursúa, Eunice D Farfán-García, Juan M Gallardo, Christian Guerra-Araiza. Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of Tau in the hippocampus of rats exposed to ozone.

(245) 1.A. Nery-Flores, S. D., Mendoza-Magaña, M. L., Ramírez-Herrera, M. A., Ramírez-Vázquez, J. D. J., Romero-Prado, M. M. D. J., Cortez-Álvarez, C. R., & Ramírez-Mendoza, A. A. (2018). Curcumin Exerted Neuroprotection against Ozone-Induced Oxidative Damage and Decreased NF-κB Activation in Rat Hippocampus and Serum Levels of Inflammatory Cytokines. Oxidative medicine and cellular longevity, 2018: 9620684.

(246) 2.A. Yao, K., Zhao, Y. F., & Zu, H. B. (2019). Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells. Drug design, development and therapy, 13, 387.

(247) 3. A. Nery-Flores, S. D., Ramírez-Herrera, M. A., Mendoza-Magaña, M. L., Romero-Prado, M. M. D. J., Ramírez-Vázquez, J. D. J., Bañuelos-Pineda, J., ... & Tostado, M. C. (2019). Dietary Curcumin Prevented Astrocytosis, Microgliosis, and Apoptosis Caused by Acute and Chronic Exposure to Ozone. Molecules, 24(15), 2839.

33. Julia, J., Fabiola Jimena, C. F., Eunice Dalet, F. G., Jose Guadalupe, T. F., & Marvin Antonio, S. U. (2017). Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases. Current pharmaceutical design, 23(21), 3120-3133

(248) 1. A. Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., ... & Gendelman, H. E. (2018). Neurotheranostics as personalized medicines. Advanced drug delivery reviews. 10.1016/j.addr.2018.10.011

(249) 2. A. McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2018). Neurotheranostics as personalized medicines.

(250) 3. B. Correa-Basurto, J. (2017). Pharmaceutical Applications of Dendrimers. Current pharmaceutical design, 23(21), 3047.

34. Pérez-Rodríguez, M., García-Mendoza, E., Farfán-García, E. D., Das, B. C., Ciprés-Flores, F. J., Trujillo-Ferrara, J. G., ... & Soriano-Ursúa, M. A. (2017). Not all boronic acids with a five-membered cycle induce tremor, neuronal damage and decreased dopamine. Neurotoxicology, 62, 92-99

(251) 1. A. Geyikoglu, F., Koc, K., Colak, S., Erol, H. S., Cerig, S., Yardimci, B. K., ... & Ozek, N. S. (2019). Propolis and Its Combination with Boric Acid Protect Against Ischemia/Reperfusion-Induced Acute Kidney Injury by Inhibiting Oxidative Stress, Inflammation, DNA Damage, and Apoptosis in Rats. Biological trace element research, 1-8. Doi: 10.1007/s12011-019-1649-2.

(252) 2. A. Geyikoglu, F., Koc, K., Erol, H. S., Colak, S., Ayer, H., Jama, S., ... & Saglam, Y. S. (2019). The propolis and boric acid can be highly suitable, alone/or as a combinatory approach on ovary ischemia-reperfusion injury. Archives of Gynecology and Obstetrics, 1-8. Doi: 10.1007/s00404-019-05303-9

35. Soriano-Ursúa, M. A., Bello, M., Hernández-Martínez, C. F., Santillán-Torres, I., Guerrero-Ramírez, R., Correa-Basurto, J., ... & Trujillo-Ferrara, J. G. (2019). Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and guinea pig beta2 adrenoceptors. European Biophysics Journal, 48(1), 83-97

(253) 1. A. Zainul, R. SILVER SULFATE (Ag2SO4): MOLECULAR ANALYSIS AND ION TRANSPORT. https://osf.io/preprints/inarxiv/n8g9k/ Inarxiv. Doi: 10.31227/osf.io/n8g9k

36. Correa-Basurto, A. M., Romero-Castro, A., Correa-Basurto, J., Hernández-Rodríguez, M., Soriano-Ursúa, M. A., García-Machorro, J., ... & Mendieta-Wejebe, J. E. (2019). Pharmacokinetics and tissue distribution of N-(2-hydroxyphenyl)-2-propylpentanamide in Wistar Rats and its binding properties to human serum albumin. Journal of pharmaceutical and biomedical analysis, 162, 130-139.

(254) 1. A. Ramírez Farías, C. G. (2018). Evaluación del anticancerigeno n-(2-hidroxifenil)-2-propilpentanamida en un modelo de cáncer mamario alotransplantado a la cápsula renal de animales receptores (Doctoral dissertation, Universidad Autónoma de Aguascalientes). URI: http://hdl.handle.net/11317/1595

37. López-Cabrera, Y., Castillo-García, E. L., Altamirano-Espino, J. A., Pérez-Capistran, T., Farfán-García, E. D., Trujillo-Ferrara, J. G., & Soriano-Ursúa, M. A. (2018). Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats. Journal of Trace Elements in Medicine and Biology, 50, 424-429

(255) 1. A. Dwynda, I., & Zainul, R. (2018). Boric Acid (H3 (BO3): Recognize the Molecular Interactions in Solutions. InarXiv. Doi:10.31227/osf.io/6wead.

(256) 2. A. Lee, M. H., Gao, Y. T., Huang, Y. H., McGee, E. E., Lam, T., Wang, B., ... & Koshiol, J. (2019). A Metallomic Approach to Assess Associations of Serum Metal Levels With Gallstones and Gallbladder Cancer. Hepatology. Doi: 10.1002/hep.30861

(257) 3. A. Aydın, S., Demirci, S., Doğan, A., Sağraç, D., Kaşıkcı, E., & Şahin, F. (2019). Boron containing compounds promote the survival and the maintenance of pancreatic β-cells. Molecular biology reports, 1-14.

(258) 4. A. Wu, L., Wei, Y., Zhou, W. B., Zhang, Y. S., Chen, Q. H., Liu, M. X., ... & Wei, G. M. (2019). Gene expression alterations of human liver cancer cells following borax exposure. Oncology reports, 42(1), 115-130.

38. Andrade-Jorge, E., Sánchez-Labastida, L. A., Soriano-Ursúa, M. A., Guevara-Salazar, J. A., & Trujillo-Ferrara, J. G. (2018). Isoindolines/isoindoline-1, 3-diones as AChE inhibitors against Alzheimer’s disease, evaluated by an improved ultra-micro assay. Medicinal Chemistry Research, 27(9), 2187-2198.

(259) 1. A. Monteiro, A. F. M., Viana, J. D. O., Nayarisseri, A., Zondegoumba, E. N., Mendonça Junior, F. J. B., Scotti, M. T., & Scotti, L. (2018). Computational Studies Applied to Flavonoids against Alzheimer’s and Parkinson’s Diseases. Oxidative medicine and cellular longevity, 2018.

(260) 2. A. Mahajan, P. G., Dige, N. C., Vanjare, B. D., Raza, H., Hassan, M., Seo, S. Y., ... & Lee, K. H. (2019). Synthesis and biological evaluation of 1, 2, 4-triazolidine-3-thiones as potent acetylcholinesterase inhibitors: in vitro and in silico analysis through kinetics, chemoinformatics and computational approaches. Molecular Diversity, 1-19. Doi: 10.1007/s11030-019-09983-y

(261) 3. A. Şenocak, A. Synthesis, Characterization, and Molecular Docking Studies of Fluoro and Chlorophenylhydrazine Schiff Bases. Journal of the Turkish Chemical Society Section A: Chemistry, 6(3), 303-310.

39. Bello, M., Guadarrama-García, C., Velasco-Silveyra, L. M., Farfán-García, E. D., & Soriano-Ursúa, M. A. (2018). Several effects of boron are induced by uncoupling steroid hormones from their transporters in blood. Medical hypotheses, 118, 78-83.

(262) 1.A. Geyikoglu, F., Koc, K., Erol, H. S., Colak, S., Ayer, H., Jama, S., ... & Saglam, Y. S. (2019). The propolis and boric acid can be highly suitable, alone/or as a combinatory approach on ovary ischemia-reperfusion injury. Archives of Gynecology and Obstetrics, 1-8. Doi: 10.1007/s00404-019-05303-9

40. Andrade-Jorge, E., Bribiesca-Carlos, J., Martínez-Martínez, F. J., Soriano-Ursúa, M. A., Padilla-Martínez, I. I., & Trujillo-Ferrara, J. G. (2018). Crystal structure, DFT calculations and evaluation of 2-(2-(3, 4-dimethoxyphenyl) ethyl) isoindoline-1, 3-dione as AChE inhibitor. Chemistry Central Journal, 12(1), 74.

(263) 1. A. Mahajan, P. G., Dige, N. C., Vanjare, B. D., Raza, H., Hassan, M., Seo, S. Y., ... & Lee, K. H. (2019). Synthesis and biological evaluation of 1, 2, 4-triazolidine-3-thiones as potent acetylcholinesterase inhibitors: in vitro and in silico analysis through kinetics, chemoinformatics and computational approaches. Molecular Diversity, 1-19. Doi: 10.1007/s11030-019-09983-y

41. Coaviche-Yoval, A., Luna, H., Tovar-Miranda, R., Soriano-Ursúa, M. A., & Trujillo-Ferrara, J. G. (2019). Synthesis and biological evaluation of novel 2, 3-disubstituted benzofuran analogues of GABA as neurotropic agents. Medicinal Chemistry, 15(1), 77-86.

(264) 1. B. Coaviche-Yoval, A., Andrade-Jorge, E., Pérez-González, C., Luna, H., Tovar-Miranda, R., & Trujillo-Ferrara, J. G. (2019). Quantum Reality in the Selective Reduction of a Benzofuran System. Molecules, 24(11), 2061.